Breaking News Instant updates and real-time market news.

ABT

Abbott

$78.84

-1.11 (-1.39%)

08:04
03/19/19
03/19
08:04
03/19/19
08:04

Abbott announces CE Mark for Alinity m diagnostics system and assays

Abbott announced CE Mark for its Alinity m diagnostics system and assays. This new technology will help keep up with the growing demand for infectious disease testing. Alinity m will provide unprecedented flexibility in molecular diagnostic testing, allowing more tests to be done in shorter timeframes, while reducing the space and number of instruments needed to conduct large amounts of tests.

ABT Abbott
$78.84

-1.11 (-1.39%)

01/02/19
SBSH
01/02/19
DOWNGRADE
Target $68
SBSH
Sell
Abbott downgraded to Sell from Neutral at Citi
Citi analyst Amit Hazan downgraded Abbott Laboratories to Sell and lowered his price target for the shares to $68 from $72.
01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.
01/25/19
ARGS
01/25/19
NO CHANGE
Target $90
ARGS
Buy
Abbott price target raised to $90 from $80 at Argus
Argus analyst David Toung raised his price target on Abbott to $90 and kept his Buy rating after its in-line Q4 results, saying the company has demonstrated investment to drive future growth with its recent product launches becoming "meaningful contributors" to revenue. The analyst adds that Abbott's increased marketing initiatives and acquisition of new growth platforms, along with the management's strong record of execution, justify the premium valuation on the stock.
01/29/19
MSCO
01/29/19
NO CHANGE
MSCO
Mitraclip presents Abbott upside regardless of suit outcome, says Morgan Stanley
Morgan Stanley analyst David Lewis noted that Abbott (ABT) filed a complaint in Delaware and various jurisdictions outside of the U.S. alleging Edwards' (EW) Pascal device infringes on Mitraclip's intellectual property. While stating that it is currently challenging to weigh in on the probability or likelihood of success, Lewis said he believes his estimates for Mitracllip growth in 2019 are likely conservative and that he sees it as a driver of upside to Abbott growth regardless of a potential injunction. It is reasonable to assume Edwards developed Pascal in full awareness of Mitraclip's patent portfolio, said Lewis, who added that "Pascal is the second most important catalyst this year from a sentiment perspective, but less of a contributor to topline growth" for Edwards.

TODAY'S FREE FLY STORIES

IMXI

International Money Express

$13.46

-0.22 (-1.61%)

06:06
11/21/19
11/21
06:06
11/21/19
06:06
Initiation
International Money Express initiated  »

International Money…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMBL

RumbleON

$1.35

-0.18 (-11.76%)

06:06
11/21/19
11/21
06:06
11/21/19
06:06
Conference/Events
RumbleON management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BV

BrightView

$19.31

0.32 (1.69%)

06:06
11/21/19
11/21
06:06
11/21/19
06:06
Earnings
BrightView reports Q3 adjusted EPS 44c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CRM

Salesforce

$164.57

0.55 (0.34%)

06:05
11/21/19
11/21
06:05
11/21/19
06:05
Recommendations
Salesforce analyst commentary  »

Salesforce set goal of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 16

    Dec

RIO

Rio Tinto

$53.11

-1.43 (-2.62%)

06:04
11/21/19
11/21
06:04
11/21/19
06:04
Conference/Events
Rio Tinto management to meet with Jefferies »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BV

BrightView

$19.31

0.32 (1.69%)

06:03
11/21/19
11/21
06:03
11/21/19
06:03
Hot Stocks
BrightView acquires Heaviland Enterprises, Clean Cut Lawns, terms not disclosed »

BrightView announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MAR

Marriott

$132.70

-2.23 (-1.65%)

06:03
11/21/19
11/21
06:03
11/21/19
06:03
Conference/Events
Marriott management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ALNY

Alnylam

$108.26

10.27 (10.48%)

06:02
11/21/19
11/21
06:02
11/21/19
06:02
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 07

    Dec

  • 04

    Feb

AXNX

Axonics

$21.89

-1.07 (-4.66%)

06:02
11/21/19
11/21
06:02
11/21/19
06:02
Hot Stocks
Axonics enters agreement to supply Axonics r-SNM System to UTMC »

Axonics announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 20

    Nov

EIDX

Eidos Therapeutics

$55.62

-2.02 (-3.50%)

06:02
11/21/19
11/21
06:02
11/21/19
06:02
Conference/Events
Eidos Therapeutics management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KIM

Kimco Realty

$21.43

-0.235 (-1.08%)

06:02
11/21/19
11/21
06:02
11/21/19
06:02
Upgrade
Kimco Realty rating change  »

Kimco Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIAOF

Telecom Italia

$0.00

(0.00%)

05:59
11/21/19
11/21
05:59
11/21/19
05:59
Upgrade
Telecom Italia rating change  »

Telecom Italia upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$87.11

0.1 (0.11%)

, LNT

Alliant Energy

$53.15

0.57 (1.08%)

05:58
11/21/19
11/21
05:58
11/21/19
05:58
Recommendations
Duke Energy, Alliant Energy, Pinnacle West, PNM Resources, CenterPoint Energy, PSEG, Consolidated Edison analyst commentary  »

Barclays makes seven…

DUK

Duke Energy

$87.11

0.1 (0.11%)

LNT

Alliant Energy

$53.15

0.57 (1.08%)

PNW

Pinnacle West

$87.22

0.46 (0.53%)

PNM

PNM Resources

$48.79

0.32 (0.66%)

CNP

CenterPoint Energy

$24.46

-0.31 (-1.25%)

PEG

PSEG

$61.19

0.7 (1.16%)

ED

Consolidated Edison

$87.31

0.415 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 19

    Nov

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

, SCHW

Charles Schwab

$44.74

0.34 (0.77%)

05:51
11/21/19
11/21
05:51
11/21/19
05:51
Periodicals
TD Ameritrade soars 26% after CNBC says Charles Schwab buyout could come today »

Charles Schwab (SCHW) is…

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

ETFC

E-Trade

$45.88

0.88 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 22

    Nov

SPWR

SunPower

$7.41

-1.12 (-13.13%)

05:49
11/21/19
11/21
05:49
11/21/19
05:49
Syndicate
SunPower 22M share Secondary priced at $7.00 »

Goldman Sachs and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETFC

E-Trade

$45.88

0.88 (1.96%)

, SCHW

Charles Schwab

$44.74

0.34 (0.77%)

05:43
11/21/19
11/21
05:43
11/21/19
05:43
Hot Stocks
Breaking Hot Stocks news story on E-Trade, Charles Schwab, TD Ameritrade »

E-Trade drops 16c to…

ETFC

E-Trade

$45.88

0.88 (1.96%)

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 22

    Nov

KKR

KKR

$29.32

0.21 (0.72%)

05:43
11/21/19
11/21
05:43
11/21/19
05:43
Hot Stocks
KKR to sell LGC to consortium led by Cinven and Astorg, terms not disclosed »

KKR announces it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

, AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

05:43
11/21/19
11/21
05:43
11/21/19
05:43
Hot Stocks
Breaking Hot Stocks news story on Charles Schwab, TD Ameritrade »

Charles Schwab drops 1%…

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

, SCHW

Charles Schwab

$44.74

0.34 (0.77%)

05:42
11/21/19
11/21
05:42
11/21/19
05:42
Hot Stocks
Breaking Hot Stocks news story on TD Ameritrade, Charles Schwab »

TD Ameritrade jumps 13%…

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

, SCHW

Charles Schwab

$44.74

0.34 (0.77%)

05:41
11/21/19
11/21
05:41
11/21/19
05:41
Periodicals
Charles Schwab in talks to acquire TD Ameritrade, CNBC reports »

Charles Schwab (SCHW) is…

AMTD

TD Ameritrade

$41.39

0.74 (1.82%)

SCHW

Charles Schwab

$44.74

0.34 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$189.85

7.64 (4.19%)

05:40
11/21/19
11/21
05:40
11/21/19
05:40
Downgrade
RH rating change  »

RH downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$8.62

-0.03 (-0.35%)

05:39
11/21/19
11/21
05:39
11/21/19
05:39
Downgrade
MacroGenics rating change  »

MacroGenics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

HARP

Harpoon Therapeutics

$14.50

-0.22 (-1.49%)

, ABBV

AbbVie

$87.20

-1.82 (-2.04%)

05:38
11/21/19
11/21
05:38
11/21/19
05:38
Hot Stocks
Harpoon Therapeutics, AbbVie announce licensing, option collaboration »

Harpoon Therapeutics…

HARP

Harpoon Therapeutics

$14.50

-0.22 (-1.49%)

ABBV

AbbVie

$87.20

-1.82 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 07

    Dec

THDDY

TV Asahi

$0.00

(0.00%)

05:38
11/21/19
11/21
05:38
11/21/19
05:38
Downgrade
TV Asahi rating change  »

TV Asahi downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

05:37
11/21/19
11/21
05:37
11/21/19
05:37
Downgrade
Nintendo rating change  »

Nintendo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.